Basics Arcellx, Inc. Common Stock IPO Date: February 4, 2022 Sector: Healthcare Industry: Biotech Market Cap: $4.77B Activated in VL: True Average Daily Range Avg Daily Range: $1.16 | 2.71% Avg Daily Range (30 D): $1.50 | 1.78% Avg Daily Range (90 D): $1.27 | 1.69% Institutional Daily Volume Avg Daily Volume: .42M Avg Daily Volume (30 D): .4M Avg Daily Volume (90 D): .4M Trade Size Avg Trade Size (Sh.): 52 Avg Trade Size (Sh.) (30 D): 44 Avg Trade Size (Sh.) (90 D): 46 Institutional Trades Total Inst.Trades: 2,074 Avg Inst. Trade: $2.69M Avg Inst. Trade (30 D): $3.58M Avg Inst. Trade (90 D): $3.91M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.15M Avg Closing Trade (30 D): $5.3M Avg Closing Trade (90 D): $5.35M Avg Closing Volume: 79.76K     News Oct 8, 2025 @ 5:00 PM CAR T-Cell Therapy for Multiple Myeloma Market to ... Source: Delveinsight May 23, 2025 @ 1:10 PM New Data and Deal Flow Signal a Turning Point for ... Source: Prnewswire May 12, 2025 @ 5:00 PM Blood Cancer Treatment Market Sees Accelerated Gro... Source: Delveinsight Mar 5, 2025 @ 6:00 PM CAR T-cell Therapy Clinical Trial Pipeline Experie... Source: Delveinsight Feb 12, 2025 @ 8:22 PM Gilead Ups 2025 Outlook, Eyes Lenacapavir Launch F... Source: Vandana Singh Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.94 $-1.13 Diluted EPS $-.94 $-1.13 Revenue $ $ 7.55M $ 8.13M Gross Profit $ $ $ Net Income / Loss $ $ -52.77M $ -62.27M Operating Income / Loss $ $ -58.73M $ -68.9M Cost of Revenue $ $ $ Net Cash Flow $ $ -18.73M $ -24.82M PE Ratio